Prevalence of SEN viruses among injection drug users in the San Francisco Bay area

Journal of Infectious Diseases

Volumn 188, Issue 1, 2003, Pages 13-18

  Pfeiffer, Ruth M ^a   Tanaka, Yasuhito ^b   Yeo, Anthony E T ^b   Umemura, Takeji ^b   Seal, Karen H ^c   Shih, J Wai Kuo ^b   Alter, Harvey J ^b   Edlin, Brian R ^c   O'Brien, Thomas R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; ETHNIC GROUP; FEMALE; HETEROSEXUALITY; HUMAN; INJECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NEGRO; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RACE; RISK; SEN A VIRUS; SEN C VIRUS; SEN V VIRUS; SEN VIRUS; SEN VIRUS INFECTION; SEXUALITY; UNITED STATES; VIRUS INFECTION; VIRUS STRAIN;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; DNA VIRUS INFECTIONS; DNA VIRUSES; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SAN FRANCISCO; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0038574431     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375740     Document Type: Article

References (17)

1. Primi D, Fiordalisi G, Mantero JL, et al. Identification of SENV genotypes. International patent no. WO0028039, 28 May 2000. Available at: http://ep.espacenet.com/.
2. Tanaka Y, Primi D, Wang RY, et al. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 2001; 183:359-67.
3. Primi D, Sottini A. Identification and characterization of SEN virus, a family of novel DNA viruses [abstract G010]. In: Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Disease (Atlanta). Antivir Ther 2000; 5(Suppl 1):G7.
4. Umemura T, Yeo AET, Sottini A, et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001; 33:1303-11.
5. Wilson LE, Umemura T, Astemborski J, et al. Dynamics of SEN virus infection among injection drug users. J Infect Dis 2001; 184:1315-9.
6. Umemura T, Alter HJ, Tanaka E, et al. Association between SEN virus infection and hepatitis C in Japan. J Infect Dis 2001; 184:1246-51.
7. Shibata M, Wang RY, Yoshiba M, Shih JW, Alter HJ, Mitamura K. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Dis 2001; 184:400-4.
8. Rigas B, Hasan I, Rehman R, Donahue P, Wittkowski KM, Lebovics E. Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C. Lancet 2001; 358:1961-2.
9. Umemura T, Alter HJ, Tanaka E, et al. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology 2002; 35:953-9.
10. Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. J Acquir Immune Defic Syndr 1994; 7:1276-81.
11. SAS/Stat user's guide. Version 8. Cary, NC: SAS Institute, 1999.
12. Pfeiffer RM, Gail MH, Brown LM. Probability of Helicobacter pylori infection based on IgG levels and other covariates using a mixture model. J Epidemiol Biostat 2000; 5:267-75.
13. Syme SL, Balfour JL. Social determinants of disease. In: Wallace RB, ed. Maxcy-Rosenau-Last public health and preventive medicine. 14th ed. Stamford, CT: Appleton & Lange, 1998:795-814.
14. Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. J Drug Issues 1999; 29:1-16.
15. National Institutes of Health (NIH) Consensus Development Program. Interventions to prevent HIV risk behaviors. NIH consensus statement, 11-13 February 1997; 15:1-41. Available at: http://odp.od.nih.gov/consensus/cons/104/104_intro.htm.
16. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep 1998; 113(Suppl 1):97-106.
17. Edlin BR. Prevention and treatment of hepatitis C in injection drug users. Hepatology 2002; 36(Suppl 1):S210-9.